Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Quince Therapeutics (QNCX) Resolves Debt with European Investment Bank
Quince Therapeutics (QNCX) has successfully resolved its debt with the European Investment Bank by paying $5.5 million, settling outstanding obligations of $16.4 million. The biopharmaceutical company, focused on rare diseases, faces significant financial challenges as indicated by a Piotroski F-Score of 3 and ongoing losses, despite moderate institutional interest and cautious analyst recommendations. Its future market position depends on addressing operational and financial hurdles beyond this debt restructuring.